세계의 소아과 의료 시장 규모 조사 및 예측 : 유형별, 지역별 분석(2023-2030년)

Pediatrics medicine, also known as pediatrics or pediatric medicine, is a branch of medicine that focuses on the medical care of infants, children, and adolescents. It is a specialized field that deals with the physical, mental, and emotional well-being of young patients, ranging from newborns to teenagers. Pediatricians are medical doctors who specialize in pediatrics and provide healthcare for children. They are trained to diagnose and treat a wide range of medical conditions that affect children, from common illnesses like colds and ear infections to more complex conditions such as asthma, diabetes, and congenital disorders. The special group of medicines known as pediatrics includes those that are given to individuals in the pediatric patient population for a variety of purposes. These medications are prescribed for a number of diseases, including anorexia, birth defects, asthma, and others. To improve R&D spending on pediatric medications, many statutes, including the Pediatrics Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA), have been passed. Increases in the incidence of diseases including diabetes and obesity in kids, as well as increased public awareness, are the factors driving the market's growth. Increased government spending and awareness initiatives are other factors driving growth in the sector.

Moreover, the rising research and development (R&D) spending in the pharmaceutical industry plays a significant role in supporting the growth of the Pediatrics Medicine Market. As per Statista, in 2020, the total overall R&D spending in the pharmaceutical sector accounted for USD 207 billion and it is projected to reach around USD 265 billion by the year 2025. Additionally, rising technological developments in the field of pediatrics medicine are anticipated to create lucrative opportunities for the market during the forecast period. However, the side effects such as headache along with anxiety stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pediatrics Medicine Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing number of research and development activities, surging drug approvals and launches in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising pediatrics population, growing investment in the development of advanced technologies, growing pediatrics health issues, and cohesive government initiatives.

Major market players included in this report are:

• Lupin
• GlaxoSmithKline plc.
• Pfizer Inc.
• Sanofi S.A.
• F. Hoffman-La Roche Ltd
• Abbott Laboratories
• Heron Therapeutics Inc.
• Eli Lilly & Company
• Novartis A.G
• Merck Co.Ltd.

Recent Developments in the Market:

• In Dec 2021, Cosentyx (secukinumab) approved by the US FDA for the treatment of active juvenile psoriatic arthritis (JPsA) in young people two years of age and older as well as active enthesitis-related arthritis (ERA) in patients four years of age and older, according to Novartis.

Global Pediatrics Medicine Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Type, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Short-Term Illness
• Chronic Illness

By Region:

• North America
• U.S.
• Canada

• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

• Latin America
• Brazil
• Mexico

• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Pediatrics Medicine Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Pediatrics Medicine Market, by Type, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Pediatrics Medicine Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Pediatrics Medicine Market Dynamics

• 3.1. Pediatrics Medicine Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing investment in the development of advanced technologies
    • 3.1.1.2. Surging drug approvals and launches
    • 3.1.1.3. Increased government spending and awareness initiatives
  • 3.1.2. Market Challenges
    • 3.1.2.1. Side effects such as headache along with anxiety
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising technological developments in the field of pediatrics medicine

Chapter 4. Global Pediatrics Medicine Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Pediatrics Medicine Market, by Type

• 5.1. Market Snapshot
• 5.2. Global Pediatrics Medicine Market by Type, Performance - Potential Analysis
• 5.3. Global Pediatrics Medicine Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4. Pediatrics Medicine Market, Sub Segment Analysis
  • 5.4.1. Short-Term Illness
  • 5.4.2. Chronic Illness

Chapter 6. Global Pediatrics Medicine Market, Regional Analysis

• 6.1. Top Leading Countries
• 6.2. Top Emerging Countries
• 6.3. Pediatrics Medicine Market, Regional Market Snapshot
• 6.4. North America Pediatrics Medicine Market
  • 6.4.1. U.S. Pediatrics Medicine Market
    • 6.4.1.1. Type breakdown estimates & forecasts, 2020-2030
  • 6.4.2. Canada Pediatrics Medicine Market
• 6.5. Europe Pediatrics Medicine Market Snapshot
  • 6.5.1. U.K. Pediatrics Medicine Market
  • 6.5.2. Germany Pediatrics Medicine Market
  • 6.5.3. France Pediatrics Medicine Market
  • 6.5.4. Spain Pediatrics Medicine Market
  • 6.5.5. Italy Pediatrics Medicine Market
  • 6.5.6. Rest of Europe Pediatrics Medicine Market
• 6.6. Asia-Pacific Pediatrics Medicine Market Snapshot
  • 6.6.1. China Pediatrics Medicine Market
  • 6.6.2. India Pediatrics Medicine Market
  • 6.6.3. Japan Pediatrics Medicine Market
  • 6.6.4. Australia Pediatrics Medicine Market
  • 6.6.5. South Korea Pediatrics Medicine Market
  • 6.6.6. Rest of Asia Pacific Pediatrics Medicine Market
• 6.7. Latin America Pediatrics Medicine Market Snapshot
  • 6.7.1. Brazil Pediatrics Medicine Market
  • 6.7.2. Mexico Pediatrics Medicine Market
• 6.8. Middle East & Africa Pediatrics Medicine Market
  • 6.8.1. Saudi Arabia Pediatrics Medicine Market
  • 6.8.2. South Africa Pediatrics Medicine Market
  • 6.8.3. Rest of Middle East & Africa Pediatrics Medicine Market

Chapter 7. Competitive Intelligence

• 7.1. Key Company SWOT Analysis
  • 7.1.1. Company 1
  • 7.1.2. Company 2
  • 7.1.3. Company 3
• 7.2. Top Market Strategies
• 7.3. Company Profiles
  • 7.3.1. Lupin
    • 7.3.1.1. Key Information
    • 7.3.1.2. Overview
    • 7.3.1.3. Financial (Subject to Data Availability)
    • 7.3.1.4. Product Summary
    • 7.3.1.5. Recent Developments
  • 7.3.2. GlaxoSmithKline plc.
  • 7.3.3. Pfizer Inc.
  • 7.3.4. Sanofi S.A.
  • 7.3.5. F. Hoffman-La Roche Ltd
  • 7.3.6. Abbott Laboratories
  • 7.3.7. Heron Therapeutics Inc.
  • 7.3.8. Eli Lilly & Company
  • 7.3.9. Novartis A.G
  • 7.3.10. Merck Co. Ltd.

Chapter 8. Research Process

• 8.1. Research Process
  • 8.1.1. Data Mining
  • 8.1.2. Analysis
  • 8.1.3. Market Estimation
  • 8.1.4. Validation
  • 8.1.5. Publishing
• 8.2. Research Attributes
• 8.3. Research Assumption